937678-86-9

Basic information

• Product Name: 4-(4-methoxybenzyloxy)-3-bromobenzaldehyde
• Synonyms: 4-(4-methoxybenzyloxy)-3-bromobenzaldehyde
• CAS NO: 937678-86-9
• Molecular Weight: 321.17
• Mol File: 937678-86-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(4-methoxybenzyloxy)-3-bromobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-methoxybenzyloxy)-3-bromobenzaldehyde(937678-86-9)
• EPA Substance Registry System: 4-(4-methoxybenzyloxy)-3-bromobenzaldehyde(937678-86-9)

Safety Data

• Hazardous Substances Data: 937678-86-9(Hazardous Substances Data)

Upstream product

• 2973-78-6 3-bromo-4-hydroxybenzylaldehyde 
• 824-94-2 p-methoxybenzyl chloride 
• 2746-25-0 p-Methoxybenzyl bromide 

Downstream Products

• 83030-50-6 1-[3-Bromo-4-(4-methoxy-benzyloxy)-phenyl]-2-nitro-ethanol 
• 1242846-76-9 (4-(4-methoxybenzyloxy)-3-bromophenyl)-N-methylmethanamine 
• 1256644-98-0 C₁₉H₁₉BrN₄O₂ 
• 1256645-18-7 C₂₄H₂₁BrN₂O₂ 
• 83030-53-9 3-bromotyramine p-methoxybenzyl ether 
• 75513-48-3 prebastadin 1 
• 83030-54-0 3-[3-Bromo-5-(2-bromo-4-{2-{2-[3-bromo-4-(4-methoxy-benzyloxy)-phenyl]-ethylcarbamoyl}-2-[(E)-hydroxyimino]-ethyl}-phenoxy)-4-hydroxy-phenyl]-N-{2-[3-bromo-4-(4-methoxy-benzyloxy)-phenyl]-ethyl}-2-[(E)-hydroxyimino]-propionamide 
• 83047-64-7 bis-p-methoxybenzyl bastadin-2 
• 83030-55-1 N-{2-[3-Bromo-4-(4-methoxy-benzyloxy)-phenyl]-ethyl}-3-(5,3'-dibromo-5'-{2-{2-[3-bromo-4-(4-methoxy-benzyloxy)-phenyl]-ethylcarbamoyl}-2-[(E)-hydroxyimino]-ethyl}-6,2'-dihydroxy-biphenyl-3-yl)-2-[(E)-hydroxyimino]-propionamide 
• 79067-77-9 bastadin-3 
• 83030-52-8 2-Bromo-1-(4-methoxy-benzyloxy)-4-(2-nitro-ethyl)-benzene 
• 83030-51-7 2-Bromo-1-(4-methoxy-benzyloxy)-4-((E)-2-nitro-vinyl)-benzene 
• 75513-47-2 prebastadin 2 
• 1242845-54-0 (S)-2-(2-(3-trifluoromethylphenyl)-4-((4-fluoro-N-methylphenylsulfonamido)methyl)phenoxy)propanoic acid 

Relevant articles and documents

BIARYL OXYACETIC ACID COMPOUNDS

Some embodiments of the present invention include novel phenoxyacetic acids useful for the prevention and treatment of inflammatory disorders, including those affecting the respiratory system and skin. Some compounds provided include those of the general formula (I), and compounds of general formula (Ia).

Synthesis of 5-substituted benzyl-2,4-diamino pyrimidine derivatives as c-Fms kinase inhibitors

A serials of novel 5-substituted benzyl-2,4-diamino pyrimidine derivatives have been synthesized and evaluated as inhibitors of c-Fms kinase by the standard MTT method. The results showed that compound 15,5-[3-methoxy-4-(pyridine-3-yl)benzyl]-2,4-diamino pyrimidine, had an IC50 of 1.45μmol/L in inhibiting the proliferation of M-CSF-dependent myeloid leukemia cells in mice (NFS-60), which was similar with GW2580, a selective inhibitor of c-Fms kinase.